C3 and rheumatoid arthritis: A reduction of complement levels following TCZ treatment (although within normal limits) was reported in the OPTION study[10] and later by other authors, including us, in a previous study on a smaller cohort.[16–18,26] Romano et al described a reduction of C3, C4 levels below normal range in 11/16 and 9/16 RA patients during TCZ treatment.